Aquahemo（Hcy，Applied in aquatic production）
Main ingredients: Hematopoietic synergists such as: Protoporphyrin, complex of copper amino acid, organic cobalt, selenium yeast, astaxanthin, taurine, vitamin B12, plant extracts etc, and osmotic pressure regulatory factors. Organic copper content > 4,000m/kg, VB12 > 15mg/kg
This product is suitable for： Blue blood animals such as shrimp, crab and limulus.
Usage and dosage: 200g of product can mix 40kg complete feed.
Packing：10kg, 20kg.
Shelf life：18 months.
Main effects of Aquahemo (Hcy): Increase the hemocyanin of shrimps and crabs, promote nutrient transportation, and reduce the feed coefficient; Improve the oxygen-carrying capacity of shrimps and crabs, increase blood oxygen saturation; Improve the tolerance of shrimps and crabs to low dissolved oxygen and nitrite, and increase the molting speed and uniformity; Good health, blood filling, enhance terminal microcirculation, promote metabolic poison discharge; Improve immunity, improve resistance to vibrio and sporozoa.
| Company Name | Guangdong Suntheme Biotechnology Co., Ltd. | Country/Region | China |
| Business Type | business_type_options | Company Size | 50 |
| Established | May 18, 2017 | ||
| Address | |||
| Main Products | Quickhemo；Quickhemo (poultry)；Quickhemo (ruminant)；Gujing（Highly degradable toxin）； Lasso peptide；1% premix of layers / 0.5% premix of broilers；Snowflake 6.0（6% premix of beef cattle）；Aquahemo (Hcy)；Aquahemo (Hb)； | ||
Guangdong Suntheme Bio-tech Co., Ltd. is a subsidiary of Guangdong Drive Bio-tech Group Co., Ltd. (one of the first batch of A-share listed companies on the Beijing Stock Exchange, stock code: 920275). The company was established in 2017 and is located in the Guangqing Industrial Park. It mainly engages in the production of hematopoietic feed additives, hematopoietic premixes, hematopoietic concentrates, and other related products, as well as the research and development, production, and promotion of new technologies.
Since its establishment, Driven Group has been dedicated to the field of animal hematopoiesis. It has proposed three core theories of hematopoietic nutrition and obtained 36 national patents, including 1 hematopoietic technology invention patent, 1 international patent, 22 high-tech products, and 3 Guangdong brand products. It has also received numerous awards and honors such as the Science and Technology Promotion Award of the Chinese Academy of Sciences, Guangdong Province's Specialized, Refined, Unique and Innovative Small and Medium-sized Enterprises, and Guangdong Province's Innovative Small and Medium-sized Enterprises. The company's products mainly address the issue of animal anemia and immunity enhancement, thereby solving the safety problems of animal-derived foods such as meat, eggs, and milk for humans. Among them, the patented product "Quickhemo" has been widely recognized and applied in the industry due to its outstanding effects that are "visible, measurable, and comparable", and has been rated as a Guangdong brand product and a high-tech product.
In response to the current situation in the animal husbandry industry, based on years of research in hematopoietic nutrition, the company has proposed a new idea for reducing feed costs: shifting from "digestion and absorption" to "transport and utilization". It has developed a series of products that increase efficiency and reduce costs. By promoting hematopoiesis to increase oxygen, it improves the conversion and utilization rate of feed and energy, helping farms and feed mills achieve genuine cost savings and efficiency improvements.
Send Inquiry
